The US Food and Drug Administration (FDA) has cleared r4 Vascular's high pressure Vector percutaneous transluminal angioplasty (PTA) balloon catheters for treating vascular narrowings lesions and blockages. Patent pending Vector PTA ...
Tags: FDA, PTA, balloon catheters, vascular narrowings lesions, r4 Vascular